Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

972
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

853
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
853
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
860
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

780
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
780

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crohn's Disease: From Immune Dysregulation to Intestinal Damage.

Inflammation·2026
Same author

Entering a new age of innovation in IBD clinical trial design.

Med (New York, N.Y.)·2026
Same author

Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine Signaling.

Biomedicines·2026
Same author

Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium Net.

BMJ open gastroenterology·2026
Same author

Immunologic Drivers and Restraints in Colitis-Associated Colorectal Cancer.

Cancers·2026

Related Experiment Video

Updated: Feb 28, 2026

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K

Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary Care.

Silvia Salvatori1,2, Irene Marafini1,2, Giovanni Monteleone1,2

  • 1Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Journal of Clinical Medicine
|February 27, 2026
PubMed
Summary

Frailty, a decline in physical ability, impacts inflammatory bowel disease (IBD) patients. Early detection and management of frailty in IBD are crucial for better health outcomes.

Keywords:
crohn diseasefrailtyulcerative colitis

More Related Videos

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

17.2K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

703

Related Experiment Videos

Last Updated: Feb 28, 2026

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.4K
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

17.2K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

703

Area of Science:

  • Gastroenterology and Geriatrics
  • Inflammatory Bowel Disease Research
  • Clinical Frailty Assessment

Background:

  • Frailty is a complex syndrome of declining physical function and increased vulnerability.
  • While traditionally associated with aging, frailty is increasingly recognized in inflammatory bowel disease (IBD).
  • IBD's systemic effects like malnutrition and muscle loss contribute to frailty.

Purpose of the Study:

  • To review the causes, assessment, and management of frailty in IBD patients.
  • To highlight the link between inflammation and frailty in IBD.
  • To emphasize the importance of early frailty detection and intervention in IBD care.

Main Methods:

  • Literature review of studies on frailty in IBD.
  • Analysis of current frailty assessment tools in the context of IBD.
  • Synthesis of evidence on frailty's impact on IBD outcomes.

Main Results:

  • Frailty is an independent predictor of adverse outcomes in IBD, including hospitalization, surgical complications, and mortality.
  • Ongoing inflammation in IBD may contribute to the development of frailty.
  • Frailty in IBD is often underrecognized in standard clinical practice.

Conclusions:

  • Frailty significantly impacts IBD patient health, necessitating proactive management.
  • A multidisciplinary approach is required to manage frailty in IBD, addressing inflammation, nutrition, and physical function.
  • Early identification and intervention strategies for frailty are essential for improving IBD patient prognosis.